Kedrion Biopharma
Fort Lee
About Kedrion Biopharma
Kedrion Biopharma provides plasma-derived therapeutic products for use in treating serious diseases, disorders, and conditions such as hemophilia and immune system deficiencies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 5,001 – 10,000
- Estimated revenue: $1M – $10M
- Funding stage: Private Equity
- Last round: Private Equity (Sep 2022)
- Website: kedrion.com
- Phone: +39 0583767100
Industries & Categories
Health Care
Social Profiles
Canonical: https://fsome.com/organization/kedrion-biopharma-48080 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.